Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting that the S/P report shows 601 share holders of PTSC stock.

Just listened to the February conference presentation from RG, where he stated a number of currently 18.000 shareholders.

My guess would be, the 601 shareholders could be brokers/banks, who hold stock for 18.000 shareholders?

FWIW

Share
New Message
Please login to post a reply